Oppenheimer Starts (SQNM), (GNOM), (CPHD) at Outperform, (MYGN), (AFFX), (GPRO), (PACB) at Perform

In the Medical Equipment and Supplies group this evening, an analyst at Oppenheimer has initiated coverage on a number of stocks:

• Sequenom (Nasdaq: SQNM) with an Outperform rating and a $9 price target
  
• Complete Genomics (Nasdaq: GNOM) with an Outperform rating and a $13 price target
  
• Cepheid (Nasdaq: CPHD) with an Outperform rating and a $33 price target
  
• Myriad Genetics (Nasdaq: MYGN) with a Perform rating and a $22 price target
  
• Affymetrix (Nasdaq: AFFX) with a Perform rating
  
• Gen-Probe (Nasdaq: GPRO) with a Perform rating and a $71 price target
  
• Pacific Biosciences (Nasdaq: PACB) with a Perform rating and a $15 price target

Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Needham Starts Faeth Therapeutics (FTH) at Buy
• Baird Starts Eaton Corporation (ETN) at Outperform
• Keefe, Bruyette & Woods Resumes Royal Bank of Canada (RY:CN) (RY) at Market Perform